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Abstract: Directing angiogenic differentiation of mesenchymal stem cells (MSCs) still remains
challenging for successful tissue engineering. Without blood vessel formation, stem cell-based
approaches are unable to fully regenerate damaged tissues due to limited support for cell viability and
desired tissue/organ functionality. Herein, we report in situ cross-linkable gelatin−hydroxyphenyl
propionic acid (GH) hydrogels that can induce pro-angiogenic profiles of MSCs via purely
material-driven effects. This hydrogel directed endothelial differentiation of mouse and human
patient-derived MSCs through integrin-mediated interactions at the cell-material interface, thereby
promoting perfusable blood vessel formation in vitro and in vivo. The causative roles of specific
integrin types (α1 and αvβ3) in directing endothelial differentiation were verified by blocking the
integrin functions with chemical inhibitors. In addition, to verify the material-driven effect is not
species-specific, we confirmed in vitro endothelial differentiation and in vivo blood vessel formation
of patient-derived human MSCs by this hydrogel. These findings provide new insight into how
purely material-driven effects can direct endothelial differentiation of MSCs, thereby promoting
vascularization of scaffolds towards tissue engineering and regenerative medicine applications
in humans.
Keywords: injectable gelatin hydrogels; patient-derived mesenchymal stem cells; integrin-mediated
interactions; material-driven endothelial differentiation; angiogenesis
1. Introduction
Over the past few decades, stem cell therapies have demonstrated a certain degree of clinical
success for thin tissues such as skin and cartilage [1–3]. These favorable outcomes have generated
additional enthusiasm that these therapies could be translated to regenerate metabolically active
tissues and organs with support from biomaterials. These therapeutic targets, however, require a
high degree of vascularization to support influx and outflux of nutrients, oxygen, and waste products
because if there are no blood vessels within any 200 µm (maximum) area, cells and tissue undergo
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necrosis [4]. Without blood vessel formation, stem cell-based approaches will not be fully successful in
regenerating damaged tissues, particularly thick tissues, due to limited support for cell viability and
desired tissue/organ functionality.
Continuous progress has been made to promote vascularization of scaffolds by incorporating or
conjugating vascular growth/signaling factors (e.g., vascular endothelial growth factor; VEGF) [4–7].
While these approaches are effective in vitro, their in vivo effects are still questionable due to a short
half-life (<30 min) of biological molecules under physiological conditions, and side effects associated
with hypotension and edema [8–10]. Therefore, several methods have been considered in order to
increase growth factor bioactivity over extended periods of time such as (i) incorporating components
of the normal extracellular matrix (ECM) (e.g., heparin and fibronectin) that stabilize these factors
and/or promote their activity; (ii) encapsulating growth factors in protease-resistant reservoirs that
serve as a physical barrier against protease attack; and (iii) engineering proteolytic cleavage sites
within growth factor proteins to inhibit their degradation [11,12]. However, there are still concerns
about the expensive supply of growth factors and paracrine side effects associated with uncontrolled
release into systemic circulation.
To address this unmet need, purely scaffold material-driven effects have been explored [13–16].
Controlling material properties at the cell–material interface (e.g., matrix stiffness and integrin–matrix
interactions) can direct stem cell differentiation, which includes endothelial differentiation of
mesenchymal stem cells (MSCs) [1,17]. For example, hydrogels have many advantages to mimic
tissue properties due to tunable properties, including hydration and stiffness [18,19]. Moreover, their
injectable format can provide a 3D microenvironment when cells are encapsulated and delivered to
a target site. We previously developed an in situ forming gelatin−hydroxyphenyl propionic acid
(GH) hydrogel. This hydrogel type was used as an injectable/sprayable platform upon a horseradish
peroxidase (HRP)-mediated cross-linking reaction to deliver therapeutic cells and drugs [20–22]. In
particular, this gelatin hydrogel, within a specific range of mechanical stiffness (0.5−3 kPa), was found
to direct robust differentiation of mouse bone marrow-derived MSCs (mMSCs) into endothelial cells,
and induce extensive vasculogenesis without any biological supplementation in vitro and in vivo [23].
In the present follow-up study, we accomplished the following three objectives. First, we identified
a mechanism at the cell–matrix interface that is responsible for directed differentiation of mMSCs into
endothelial cells. The causative roles of specific integrin types (α1 and αvβ3) in directing endothelial
differentiation were verified by blocking the integrin functions with chemical inhibitors. Second, to
verify the material-driven effect is not species-specific, we confirmed in vitro endothelial differentiation
of patient-derived human MSCs (hMSCs) by this hydrogel. Third, we confirmed consequent, improved
blood vessel formation of these patient hMSCs when delivered through the gelatin hydrogel system in
a subcutaneous implantation model of immune compromised mice.
While only about ~300 genes out of approximately 20,000 are unique to either humans or mice as
revealed from whole genome sequencing, interspecies differences have been rather difficult to predict
and understand at times, as evidenced by countless clinical trials that have ultimately failed after
successful pre-clinical studies in mice [24]. Therefore, robust validation in human patient-derived
MSCs is required for successful translation. To this end, we have isolated bone marrow-derived MSCs
from three patients, particularly from old patients (>65 years old) as they stand to benefit the most from
regenerative medicine approaches. This approach is necessary to provide new insight into how purely
material-driven effects can direct endothelial differentiation of MSCs, thereby promoting vascularization
of scaffolds towards tissue engineering and regenerative medicine applications in humans.
2. Results and Discussion
2.1. Characterization of In Situ Forming Gelatin−Hydroxyphenyl Propionic Acid (GH) Hydrogels
To prepare in situ cross-linkable gelatin hydrogels, we first synthesized HRP-reactive
phenol-conjugated gelatin polymer (GH conjugate, phenolic content = 143 µmol/g of polymer).
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This GH polymer solution (7 wt %) dissolved in PBS (pH 7.4) was subjected to HRP/H2O2-tiggered
oxidative cross-linking (Figure 1A) [21]. Based upon our previous findings that GH hydrogels with
<3 kPa mechanical stiffness led to robust vasculogenic induction of mMSCs in vitro and in vivo,
we prepared two different GH hydrogels with distinct degrees of mechanical strength (GH-7-L; 1.4 kPa
and GH-7-H; 3.0 kPa) for the present study [23]. The softer hydrogels (<1.0 kPa) were excluded because
of fast degradation within a few days in in vitro cell experiments [23].
To characterize the mechanical stiffness of GH hydrogels formed with HRP (2.5 µg/mL) and H2O2
(0.005 wt % for GH-7-L and 0.006 wt % for GH-7-H), we investigated H2O2 concentration-dependent
viscoelastic modulus (G’ and G”) as a function of time (Figure 1B,C). The time point at which G’ and
G” intersect each other (G’ > G”) is defined as a hydrogel formation [25]. The HRP/H2O2 interactions
catalyzed in situ cross-linking among phenolic groups of GH conjugates, and thus resulted in a rapid
gelation where an intersected point of G’/G” was observed within 15 s. In addition, higher H2O2
concentration led to a greater G’ of hydrogels due to the increased cross-linking density where it was
confirmed that G’ of GH-7-L and GH-7-H were 1.4 and 3.0 kPa, respectively. We also characterized
proteolytic degradation rates of GH-7-L and GH-7-H gels incubated in the media with or without
collagenase solution (0.4 µg/mL) as a function of time. As shown in Figure 1D, GH-7-L and GH-7-H
hydrogels completely degraded within 24 and 53 h, respectively, whereas the GH-7-L gels incubated
in the media without collagenase were stable for 53 h. This result indicates that GH hydrogels can be
degraded through the decomposition of gelatin backbone by matrix metalloproteases present in the
body, and their degradation rate is dependent on the cross-linking density.
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2.2. Gelatin Hydrogel Material-Driven Differentiation of MSCs (Mesenchymal Stem Cells) into
Endothelial Cells
We next investigated the interfacial mechanism behind purely gelatin material-driven
differentiation of MSCs into an endothelial lineage. While a number of previous studies have
shown purely material-driven differentiation of MSCs into osteocytes, neural cells, and chondrocytes,
endothelial differentiation most commonly required an extensive use of biochemical agents such
as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) [26–28]. In our
previous study, we also observed an increased expression of VEGF receptor 2 in mMSCs cultured in
GH hydrogels without any addition of growth factors [23]. Therefore, we hypothesized that integrins
at the cell-matrix interface might play a key role in inducing the endothelial differentiation of MSCs.
Integrins are extracellular matrix receptors expressed on the cell membrane, and they serve as a
physical anchoring point for adherent cells. Seminal studies have shown that many integrins are
responsible for mediating cell–matrix interaction [29,30]. For example, integrins α1-3 and α6 with their
downstream signaling are crucial in driving MSC differentiation to an endothelial lineage by binding
to a mixed laminin I and collagen IV substrate. Therefore, inquiring if integrin binding to the GH
hydrogel caused endothelial differentiation of mMSCs, as seen in our previous work, would suggest
that translation to hMSCs is possible as they express the same integrins.
In order to identify the types of integrin involved in the material-driven effect on mMSCs,
we profiled expression of various integrins through qRT-PCR (Figure 2A). Of 26 integrins known to
date, we focused on specific integrins that bind to collagen and other ECM components involved in
angiogenesis. Integrin α1 (collagen receptor) expression of mMSCs in GH-7-L and GH-7-H gels were
significantly upregulated (3.8−4.9 times) compared to the TCPS condition. Additionally, integrin αv
and β3, together forming a heterodimer that plays a significant role in angiogenesis, were shown to
be upregulated. Lastly, ERK1, a key downstream signaling molecule in endothelial differentiation,
was significantly upregulated as well.
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Figure 2. Integrin-mediated mechanisms at the cell–material interface. mRNA expression levels
of mMSCs cultured for 15 days either on tissue culture polystyrene (TCPS) (control) or embedded
in GH-7-L and GH-7-H hydrogels, * p < 0.05 vs. TCPS (n = 3) (A); Integrin inhibition effects on
connectivity of blood vessels formed when mMSCs were cultured in GH-7-L and GH-7-H hydrogels.
The experiment groups include mMSCs cultured on TCPS, GH-7-L, and GH-7-H gels for 15 days with
no treatment, soluble vascular endothelial growth factor (VEGF), P11 (integrin αvβ3 inhibitor), and
obtustatin (integrin α1 inhibitor). Scale bars indicate 200 µm (B).
We then observed sprouting morphology of mMSC cultured in GH hyd ogels when integrin
functions w re sel ctively blocked with chemical inhibitors in rder to verify their causat ve roles
for directing endothelial differentiation (i.e., integrin αvβ3 inhibitor; P11 an integrin α1 inhibitor;
obtustatin). We also included a positive control where soluble VEGF was added in media. As shown
in Figure 2B, addition of VEGF improved the degree and connectivity of vasculogenesis in GH
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hydrogel matrix. However, inhibitor treatment (P11 or obtustatin) attenuated the material-driven
effect. P11-treated cells stayed rounded for 15 days, while obtustatin-treated cells tended to aggregate
into large clumps with limited vessel sprouting. These results suggest that both integrins α1 and αvβ3
are crucial in driving endothelial differentiation of mMSCs in gelatin hydrogels.
2.3. In Vitro Endothelial Differentiation of Patient-Derived MSCs in GH Hydrogels
Because we confirmed that material-mediated engagement of integrins triggered mMSC
differentiation into endothelial cells, we set out to demonstrate translation to hMSCs from
representative human donors. Patient-derived hMSCs (donor 1−3; >65 years old-patients), were
harvested from bone marrow biopsies, and characterized for purity of isolation. For in vitro
experiments, hMSCs were encapsulated in GH gel matrix, and their viability, spreading, and
endothelial differentiation of hMSCs were investigated. As seen in Figure 3A,B, live/dead staining
images demonstrated excellent survival (>80%) of hMSCs in both GH-7-L and GH-7-H gels throughout
the culture period. hMSCs appeared rounded at day 1, but began spreading through the GH matrix over
14 days. Although there was a certain degree of donor-to-donor variation, GH-7-L with lower stiffness
revealed better well-elongated and interconnected cell morphology than GH-7-H. The reason why
hMSCs cultured in GH-7-L gels spread more is likely due to a faster degradation rate of cross-linked
gelatin matrix, which leaves more room for cell spreading and nutrient/oxygen transport. In addition,
other previous studies also demonstrated that lower cross-linking density resulted in an increase
in mesh size, swelling degree, and degradation rate, thus enhanced cellular activities such as cell
migration and growth in 3D cell culture system [31,32].
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Figure 3. In vitro endothelial differentiation of patient- eri e s cultured in GH hydrogels.
Live/dead staining images of hMSCs in GH-7-L and GH-7- gels on days 1 and 14 post culture. Scale
bars = 100 µm (A); Quantification of viable cells (%) at day 1 and 14 (B); R A expression levels of
endothelial cell markers (FLK1 and CD31) in hMSCs determined by qRT-PCR after 21 days of culture
in GH gels. As a control, the same number of cells was seed on TCPS. * p < 0.05 vs. TCPS (n = 3) (C).
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To verify endothelial differentiation of hMSCs in GH hydrogels, we analyzed gene expression
of vascular-endothelial lineage markers (i.e., FLK1 and CD31). For comparison, the same density
of cells was also cultured on TCPS as a control. Overall, the expression of endothelial markers in
hMSCs cultured in GH gel was significantly upregulated (2.4–6.3-fold for FLK1 and 1.1–3.2-fold
CD31, donor 1−3) as compared to TCPS control (Figure 3C). However, no significant difference
between GH-7-L and GH-7-H was observed. Taken together, our results demonstrate that the GH
hydrogels can promote endothelial differentiation of patient-derived hMSCs in vitro without addition
of pro-angiogenic supplements, which is comparable to what was shown with mMSCs [23].
2.4. In Vivo Vascularization of hMSCs Delivered with GH Hydrogel
Finally, to examine if hMSCs (donor 1−3) in GH hydrogels induced angiogenesis in vivo,
we subcutaneously delivered cells in GH gel loaded on PVA scaffolds in immunodeficient mice [23].
The use of immunodeficient mice was necessary in order to avoid severe immune response and
eventual rejection of hMSCs derived from unmatched donor to recipient species. Two weeks
post-implantation, mice were perfused with a heparinized fluorescent microbead solution for imaging
and quantification of perfusable vascular formation. Figure 4A shows fluorescence images of surface
and cross-section of scaffolds by fluorescent angiography, and Figure 4B shows the quantification
results on relative ratio of blood vessel area % to control. While the non-crosslinked control showed
limited vascularization both on the surface and cross-section of the implants, hMSCs in cross-linked
GH-7 gels substantially increased vessel formation. In particular, GH-7-H hydrogels most induced
blood vessel formation (2.3-fold for surface and 1.9-fold for cross-section, * p < 0.05) compared to
the control. When GH hydrogels were incubated in vitro with the collagenase as one of the matrix
metalloproteinase (MMP) existing in the body, it was found that GH-7-H hydrogels was relatively stable
than GH-7-L hydrogel. Accordingly, we speculate that the GH-7-H hydrogel provided more effective
biomechanical structure than the non-crosslinked control and GH-7-L gel for cell survival/retention,
and consequently supported functional vascularization of hMSCs.
Int. J. Mol. Sci. 2017, 18, 1705  6 of 11 
 
To verify endothelial differentiation of hMSCs in GH hydrogels, we analyzed gene expression 
of vascular-endothelial lineage markers (i.e., FLK1 and CD31). For comparison, the same density of 
cells was also cultured on TCPS as a control. Overall, the expression of endothelial markers in hMSCs 
cultured in GH gel was significantly upregulated (2.4–6.3-fold for FLK1 and 1.1–3.2-fold CD31, donor 
1−3) as compared to TCPS control (Figure 3C). However, no significant diﬀerence between GH-7-L 
and GH-7-H was observed. Taken together, our results demonstrate that the GH hydrogels can 
promote endothelial differentiation of patient-derived hMSCs in vitro without addition of pro-
angiogenic supplements, which is comparable to what was shown with mMSCs [23]. 
2.4. In Vivo Vascularization of hMSCs Delivered with GH Hydrogel 
Finally, to examine if hMSCs (donor 1−3) in GH hydrogels induced angiogenesis in vivo, we 
subcutaneously delivered cells in GH gel loaded on PVA scaffolds in immunodeficient mice [23]. The 
use of immunodeficient mice was necessary in order to avoid severe immune response and eventual 
rejection of hMSCs derived from unmatched donor to recipient species. Two weeks post-
implantation, mice were perfused with a heparinized fluorescent microbead solution for imaging and 
quantification of perfusable vascular formation. Figure 4A shows fluorescence images of surface and 
cross-section of scaffolds by fluorescent angiography, and Figure 4B shows the quantification results 
on relative ratio of blood vessel area % to control. While the non-crosslinked control showed limited 
vascularization both on the surface and cross-section of the implants, hMSCs in cross-linked GH-7 
gels substantially increased vessel formation. In particular, GH-7-H hydrogels most induced blood 
vessel formation (2.3-fold for surface and 1.9-fold for cross-section, * p < 0.05) compared to the control. 
When GH hydrogels were incubated in vitro with the collagenase as one of the matrix 
metalloproteinase (MMP) existing in the body, it was found that GH-7-H hydrogels was relatively 
stable than GH-7-L hydrogel. Accordingly, we speculate that the GH-7-H hydrogel provided more 
effective biomechanical structure than the non-crosslinked control and GH-7-L gel for cell 
survival/retention, and consequently supported functional vascularization of hMSCs. 
 
Figure 4. In vivo vascularization of hMSCs with GH hydrogels subcuntaneously delivered into nude 
mice. Representative images (surface and cross-section) of perfusable vasculature from delivered 
hMSCs in the GH gel loaded on polyvinyl alcohol (PVA) implants at two weeks post implantation. 
Yellow lines mark the surface boundaries of implants, and scale bars indicate 200 µm (A); Relative 
ratio of functional blood vessels by crosslinked GH-7-L and GH-7-H gels compared to non-
crosslinked GH control (ratio = 1). * p < 0.05 vs. Control (n = 3, from mixed donor cell groups) (B). 
3. Materials and Methods  
3.1. Materials  
Gelatin (from porcine skin, Type A, >300 bloom), 3-(4-hydroxyphenyl) propionic acid (HPA), 1-
ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), N-hydroxysuccinimide (NHS), hydrogen 
peroxide (H2O2), and horseradish peroxidase (HRP, type VI, 250-330 units/mg solid) were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Dimethylformamide (DMF) was obtained from Junsei 
(Junsei, Tokyo, Japan). 
Figure 4. I vivo vasc larizatio of h S s ith hy rogels subcuntaneously delivered into nude
ice. i i r s - i f perf s l vasc l t r fro delivered
h S s in the gel loade o poly i l alc l ( ) i la ts at t o ee s st i l t ti .
Yellow lines mark the surface boundaries of implants, and scale bars indicate 200 µm (A); Relativ ratio
of functional blood vessels by crosslinked GH-7-L and GH-7-H gels compared to non-crosslinked GH
control (ratio = 1). * p < 0.05 vs. Control (n = 3, from mixed donor cell groups) (B).
3. t rials a et o s
3.1. aterials
elatin (fro porcine skin, ype , >300 bloom), 3-(4-hydroxyphenyl) propionic acid (HPA),
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), -hydroxysuccinimide ( S), hydrogen
peroxide (H2 2), and horseradish peroxidase ( P, type VI, 250-330 units/ g solid) ere purchased
Int. J. Mol. Sci. 2017, 18, 1705 7 of 11
from Sigma-Aldrich (St. Louis, MO, USA). Dimethylformamide (DMF) was obtained from Junsei
(Junsei, Tokyo, Japan).
HRP-reactive GH polymer was synthesized by conjugating HPA to the gelatin backbone as
previously described [23]. In brief, HPA (20 mmol) was activated with EDC (20 mmol) and NHS
(27.8 mmol) in 15 mL of co-solvent (volume ratio of deionized water and DMF = 3:2). After HPA
activation for 1 h, the mixture was added to the pre-heated gelatin solution (5 g in 150 mL of deionized
water). The reaction was carried out at 40 ◦C for 24 h. The resulting solution was purified using
a dialysis membrane (MWCO = 3.5 kDa) against deionized water for 3 days, and lyophilized to
obtain the GH polymer. The conjugated HPA amount of GH polymer was measured by UV–VIS
spectrophotometer (V-750, Jasco, Japan) at 275 nm, and determined to be 143 µmol/g of polymer for
this study.
3.2. Preparation and Characterization of GH Hydrogels with Different Mechanical Stiffness
GH hydrogels were prepared by simply mixing aqueous GH polymer solution in presence of
HRP and H2O2. The pre-heated GH solution (7 wt %) at 40 ◦C was divided into two aliquots: (1) HRP
(2.5 µg/mL) was added to one aliquot, and (2) H2O2 (0.005 wt % for GH-7-L and 0.006 wt % for
GH-7-H) was added to another aliquot (volume ratio of GH:HRP and GH:H2O2 = 9:1, respectively).
Lastly, two aliquots were mixed to generate in situ cross-linked GH hydrogels.
For characterization of gelation kinetics and mechanical stiffness of GH hydrogels formed with
different H2O2 concentrations, the time-sweep elastic (G’) and viscous (G”) modulus of hydrogels
(300 µL) were measured at 37 ◦C for 5 min using an Advanced Rheometer GEM-150-050 (Bohlin
Instruments, East Brunswick, NJ, USA) in oscillation mode (strain = 0.01% and frequency = 0.1 Hz,
gap = 0.5 mm).
For in vitro proteolytic degradation testing, GH-7-L and GH-7-H gels were formed in a microtube,
and incubated in 1 mL PBS (pH 7.4) with or without 0.4 µg/mL of collagenase (type II, Sigma-Aldrich).
At a predetermined time point, the weight of each hydrogel was recorded after removing media,
and fresh media was then added for the next time point. The degradation degree of hydrogels was
determined by measuring the weight change of initially formed gels with respect to the degraded gels
at each time point [20].
3.3. In Vitro 3D Culture of hMSC in GH Hydrogels
hMSCs were isolated from the bone marrow of male patients (>65 in age) free from any
blood disorders and cancer (hMSC harvest approved by Vanderbilt University Medical Center
IRB#150133 February, 2015). FACS was used to isolate hMSCs that are CD14-/CD20-/CD34-/CD73+/
CD90+/CD105+. Cells (donor 1−3) were suspended in GH + HRP solution at the concentration
of 2 × 106 cells/mL, and this suspension was then mixed with GH + H2O2 solution to make GH
hydrogels incorporating cells. As a control, the same number of cells was also seeded on tissue
culture plate (TCPS) without GH hydrogel. After GH hydrogels were formed on the well plate, DMEM
supplemented with 10% FBS and 1% penicillin-streptomycin was added, and media was changed every
1–2 days. For the inhibition study, murine MSCs (mMSCs, GIBCO) were used with same conditions
and procedures as described above. P11 (EMD Millipore, Billerica, MA, USA) was used at 10 µM,
obtustatin (Tocris Biosciences, Bristol, UK) at 10 nM, and mVEGF (Sino Biological Inc., North Wales,
PA, USA) at 50 ng/mL as supplements [33,34]. The cellular morphological changes ofcells cultured in
GH hydrogels for 15 days were observed by a Nikon Eclipse Ti microscope.
For live/dead staining assay, hMSCs (donor 1–3) cultured in GH-7-L and GH-7-H hydrogels for 1
and 14 days were stained with media containing 1 µg/mL propidium iodide (Sigma-Aldrich, St. Louis,
MO, USA) and 1 µM calcein AM (Invitrogen, Carlsbad, CA, USA) for 15 min, and then the live/dead
cells were identified using a Zeiss 710 confocal laser microscope.
For quantitative polymerase chain reaction (qRT-PCR) analysis, cells encapsulated within GH
hydrogels were homogenized with the Trizol reagent (Life Technologies) mixed with chloroform
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(volume ratio of Trizol and chloroform = 1:5), and phase-separated by centrifugation (15 min, 4 ◦C).
The aqueous phase containing RNA was isolated with RNeasy columns (Bio-Rad, Hercules, CA, USA)
according to the manufacturer’s instructions. cDNA was synthesized using a high-capacity cDNA
reverse transcriptase kit (Applied Biosystems, Life Technologies, Foster City, CA, USA), and qRT-PCR
was performed with a SYBR Green master mix (Bio-Rad) with 15–20 ng cDNA and 500 nM each of
forward and reverse primers, using a CFX Real-Time PCR System (Bio-Rad). The qRT-PCR protocol
included: 95 ◦C for 3 min, followed by 40 cycles of denaturation at 95 ◦C for 30 s, annealing at 58 ◦C for
30 s, and extension at 72 ◦C for 30 s. Expression of each gene of interest was normalized to expression
of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a housekeeping gene, generating the ∆Ct
value, and expression of 2−∆∆Ct relative to the TCPS control with n ≥ 3 biological replicates for each
experiment is reported. Primer sequences are listed in Table 1, and only those that showed single,
specific amplicons were used for qRT-PCR experiments.
Table 1. Primer sequences used for quantitative real-time polymerase chain reaction (qRT-PCR).
Gene Accession Number Forward Primer (5′–3′) Reverse Primer (3′–5′) Species
Integrin α1 NM_001033228.3 TCAGTGGAGAGCAGATCGGA CCCACAGGGCTCATTCTTGT Mouse
Integrin αv NM_008402.3 GTGCCAGCCCATTGAGTTTG TGGAGCACAGGCCAAGATTT Mouse
Integrin β3 NM_016780.2 GCCTGGTGCTCAGATGAGACT GATCTTCGAATCATCTGGCCG Mouse
ERK1 NM_011952.2 CAACCCAAACAAGCGCATCA AGGAGCAGGACCAGATCCAA Mouse
GAPDH NM_001289726 TGAAGCAGGCATCTGAGGG CGAAGGTGGAAGAGTGGGAG Mouse
FLK1 NM_002253.2 GAGGGGAACTGAAGACAGGC GGCCAAGAGGCTTACCTAGC Human
CD31 NM_000442.4 CCAAGCCCGAACTGGAATCT CACTGTCCGACTTTGAGGCT Human
GAPDH NM_002046.4 GCACCGTCAAGGCTGAGAAC TGGTGAAGACGCCAGTGGA Human
3.4. hMSC Delivery in GH Hydrogels on Polyvinyl Alcohol (PVA) Scaffolds In Vivo
The animal experiment was approved by Vanderbilt Institutional Animal Care and Use Committee
(IACUC) in accordance with the NIH Guide for the Care and Use of Laboratory Animals (IACUC
number: M1600003 approved on 2 June 2015). GH polymer (7 wt %) and H2O2 (0.005 and 0.006 wt %)
were dissolved in DMEM media as described above, while a constant HRP concentration (2.5 µg/mL)
was used for all conditions. The procedures for in vivo animal study are comparable to that
previously reported [23]. hMSCs (5 × 105 cells)-containing GH hydrogel solutions in a total volume
of 60 µL were loaded on porous PVA scaffolds (6 mm in diameter, Medtronics, Dublin, Ireland).
As a control, porous PVA scaffolds loaded with non-crosslinked GH solution containing hMSCs were
implanted. The gel-scaffold complexes were then subcutaneously implanted on the ventral side of
immunodeficient NU/J mice (male, five-months-old) for two weeks. A longitudinal incision (15 mm)
was made on the ventral side of mice, and three different gel-scaffold complexes (donor 1−3) were
inserted into individual subcutaneous pockets. The skin incision was closed with sutures.
At two-weeks post implantation, mice were perfused under heavy, near-lethal level of anesthesia
with 4% isoflurane in 2 L/min oxygen. First, heparin sulfate (0.1 mg/mL) solution dissolved in PBS
was injected into the left ventricle to exsanguinate through the cut inferior vena cava. Mice were then
perfused with PBS containing fluorescent micro-beads (Invitrogen) for micro-angiography. Scaffolds
were subsequently harvested, and analyzed for angiogenesis by micro-angiography using as described
previously [35]. Fluorescence images were obtained using a Zeiss 710 confocal laser microscope. ImageJ
software (National Institutes of Health; NIH, USA, Version 1.48) was used for all image preparation
and analysis, including z-stacking fluorescence images and quantification.
3.5. Statistical Analysis
All results are expressed as mean ± standard deviation. Comparisons among samples in in vitro
and in vivo quantitative analysis were performed by a Student’s t-test, and p < 0.05 was considered
statically significant.
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4. Conclusions
Based on these results, we suggest in situ cross-linked GH hydrogels as a promising tissue
engineering template to promote scaffold vascularization using hMSCs. Not only was it found that the
material engaged with integrins to trigger endothelial differentiation, these results adds a substantial
value to ongoing research in the field as perfusable vasculature can be generated with hMSCs sourced
from older donors who would more likely take advantage of stem cell therapies. A future study
will be designed to tune the GH hydrogel system to encapsulate more than one type of stem cell or
co-culture MSCs with other somatic cell types for tissue type-specific regeneration with improved
vascularization. As seen in Figure 4A, vascular networks were shown to branch out within the core
of the GH hydrogel, which is a crucial requirement to maintain metabolically active tissues and
organs that could be developed in more advanced co-culture experiments. Therefore, continuing and
gradual improvements to the chemical design of the GH hydrogel system remain a long-term goal.
In conclusion, the findings reported here illustrate an easy-to-use hydrogel system that can serve as a
translatable platform technique for generating stem cell-derived endothelialization for future tissue
engineering therapies.
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